Table 2 Baseline characteristics of patients
| Â | HFNC | Control | ||||||
|---|---|---|---|---|---|---|---|---|
Author (Year) | Age,Years Mean (SD) | Man n,(%) | SAPS II Mean(SD) | APACHE II Mean(SD) | Age,Years Mean(SD) | Man, n,(%) | SAPS II, Mean(SD) | APACHE II, Mean(SD) |
Corley 2015 | 63(11.4) | 58(72.0%) | NR | 15(3.6) | 65(11.1) | 56(76.0%) | NR | 15.0(3.9) |
Fernandez 2017 | 67.3(12.1) | 46(59.0%) | NR | 11(5.5) | 69.7(13.0) | 55(71.0%) | NR | 10.0(6.7) |
Futier 2016 | 62(12.0) | 61(56.0%) | NR | NR | 61.0(13.0) | 64(57.0%) | NR | NR |
Hernández 2016 | 51(13.1) | 164(62.1%) | NR | 7 | 51.8(12.2) | 153(58.2%) | NR | 7 |
Hernández 2016(2) | 64.6(15.4) | 186(64.1) | NR | 11 | 64.4(15.8) | 202(64.3) | NR | 10 |
Maggiore 2014 | 64(17.0) | 33(62.3%) | 44(16) | NR | 65.0(18.0) | 35(67.3%) | 43.0(14.0) | NR |
Parke 2013 | 65 | 129(76.3%) | NR | NR | 66.0 | 129(75.4%) | NR | NR |
Stéphan 2016 | 63.8 | 273(65.9%) | 29 | NR | 63.9 | 278(66.8%) | 28.8 | NR |